BAIWANG CO(06657): The Stock Exchange has approved the company's H share full circulation listing.
Baiwang Group (06657) announced that the company recently received a notice from the Stock Exchange that it has approved the...
BAIWANG CO (06657) announced that the company has recently received approval from the Hong Kong Stock Exchange on November 17, 2025 for the listing and trading of 135 million H shares (the maximum number of domestic shares to be converted and listed) to be issued.
Related Articles
FEG HOLDINGS (01413) intends to implement a "5-in-1" stock consolidation and change the minimum trading unit.
BAIC MOTOR (01958) plans to sell 51% of its equity in BAIC International for approximately 1.608 billion yuan.
CSPC PHARMA (01093): Selective 5-HT2A receptor agonist (SYH2056 tablets) receives clinical trial approval in China.
FEG HOLDINGS (01413) intends to implement a "5-in-1" stock consolidation and change the minimum trading unit.
BAIC MOTOR (01958) plans to sell 51% of its equity in BAIC International for approximately 1.608 billion yuan.
CSPC PHARMA (01093): Selective 5-HT2A receptor agonist (SYH2056 tablets) receives clinical trial approval in China.
